Acinetobacter ursingii: Difference between revisions

Latest revision as of 14:44, 7 February 2021

Background

Microbiology

Non-motile, aerobic, oxidase negative, non-fermentative, Gram-negative coccobacillus
Member of the genus Acinetobacter with low pathogenicity

Epidemiology

Rare cause of disease in humans
Mostly affects immunocompromised patients or critically ill patients
Possible association with malignancy

Clinical Manifestations

Primary bacteremia
Urinary tract infection
Hospital-associated pneumonia

Management

Often susceptible, but should still treat broadly (e.g. meropenem) and narrow based on susceptibilities

A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii. BMC Infect Dis. 2015;15(400). doi: 10.1186/s12879-015-1145-z
Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens. J Clin Microbiol. 2006;44(12):4471-4478. doi: 10.1128/JCM.01535-06

@@ Line 1: / Line 1: @@
 {{DISPLAYTITLE:''Acinetobacter ursingii''}}
-== Background ==
+==Background==
-=== Microbiology ===
+===Microbiology===
-* Non-motile, aerobic, oxidase [[Oxidase::negative]], non-fermentative, [[Stain::Gram-negative]] [[Shape::coccobacillus]]
+*Non-motile, aerobic, oxidase [[Oxidase::negative]], non-fermentative, [[Stain::Gram-negative]] [[Shape::coccobacillus]]
-* Member of the genus [[Acinetobacter species|Acinetobacter]] with low pathogenicity
+*Member of the genus [[Acinetobacter species|Acinetobacter]] with low pathogenicity
-=== Epidemiology ===
+===Epidemiology===
-* Rare cause of disease in humans
+*Rare cause of disease in humans
-* Mostly affects immunocompromised patients or critically ill patients
+*Mostly affects immunocompromised patients or critically ill patients
+*Possible association with malignancy
-== Clinical Manifestations ==
+==Clinical Manifestations==
-* Primary bacteremia
+*Primary [[bacteremia]]
+*[[Urinary tract infection]]
-* Pneumonia
+*Hospital-associated pneumonia
-== Further Reading ==
+== Management ==
+* Often susceptible, but should still treat broadly (e.g. [[meropenem]]) and narrow based on susceptibilities
-* A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of ''Acinetobacter ursingii''. ''BMC Infect Dis''. 2015;15(400). doi: [https://doi.org/10.1186/s12879-015-1145-z 10.1186/s12879-015-1145-z]
+==Further Reading==
+*A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of ''Acinetobacter ursingii''. ''BMC Infect Dis''. 2015;15(400). doi: [https://doi.org/10.1186/s12879-015-1145-z 10.1186/s12879-015-1145-z]
+*Bacterial Identification, Clinical Significance, and Antimicrobial Susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, Two Frequently Misidentified Opportunistic Pathogens. ''J Clin Microbiol''. 2006;44(12):4471-4478. doi: [https://doi.org/10.1128/JCM.01535-06 10.1128/JCM.01535-06]
 [[Category:Gram-negative bacilli]]